These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 40511)

  • 41. [Biological researches in mental patients: variations of erythrocyte osmotic resistance in schizophrenics].
    BUONDONNO E; DI SANSEBASTIANO V
    Osp Psichiatr; 1956; 24(2):113-47. PubMed ID: 13388367
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of smoking cessation on serum neuroleptic levels.
    Blumberg D; Safran M
    Am J Psychiatry; 1991 Sep; 148(9):1269. PubMed ID: 1679301
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuroleptic drug monitoring and radioreceptor assays.
    Cooper TB
    J Clin Psychopharmacol; 1985 Oct; 5(5):A15-6. PubMed ID: 2864356
    [No Abstract]   [Full Text] [Related]  

  • 44. The cell fragility of erythrocytes from schizophrenic patients.
    HOARE R
    Can Med Assoc J; 1961 May; 84(21):1201-3. PubMed ID: 13714750
    [No Abstract]   [Full Text] [Related]  

  • 45. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
    Boza RA; Milanes F; Starkey T; Slater V; Dominguez F
    J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
    [No Abstract]   [Full Text] [Related]  

  • 46. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS; Brown WA; Laughren TP; Krantz J
    Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
    [No Abstract]   [Full Text] [Related]  

  • 47. Neuroleptic concentrations in schizophrenic patients: measurements by radioreceptor assay and gas chromatography.
    Javaid JI; Davis JM; Dysken MW; Janicak P; Casper R
    Psychopharmacol Bull; 1983; 19(1):72-4. PubMed ID: 6131469
    [No Abstract]   [Full Text] [Related]  

  • 48. [The "the therapeutic window" of neuroleptic levels in the erythrocytes of schizophrenics (proceedings)].
    Yesavage JA
    Ann Med Psychol (Paris); 1979; 137(3-4):251. PubMed ID: 40511
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuroleptic-refractory patients and their drug plasma levels.
    Berrios GE
    Encephale; 1982; 8(4):465-85. PubMed ID: 6129961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolactin and neuroleptic drugs.
    Green AI; Brown WA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Practical aspects of drug resistance in schizophrenia].
    Jarema M; Kucińska M
    Psychiatr Pol; 2000; 34(5):721-40. PubMed ID: 11202015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Characteristics of the interaction of neuroleptics and antidepressants with plasma proteins (review of the literature)].
    Bender KI; Kupchikov VV; Lutsevich AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):116-24. PubMed ID: 1686128
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.